Murine models of Pneumocystis infection recapitulate human primary immune disorders

Waleed Abdel Wahab Elsegeiny,Mingquan Zheng,Taylor John Eddens,John F Alcorn,Kong Chen,Jay Kolls

DOI: https://doi.org/10.4049/jimmunol.198.supp.57.8

2017-05-01

The Journal of Immunology

Abstract:Abstract Despite the discovery of key pattern recognition receptors and CD4+ T-cell subsets in laboratory mice, there is ongoing discussion of the value of murine models to reflect human disease. We recognize a strong parallel between human and mouse CD4+ T-cell immunity using the hallmark example of CD4+ T-cell dependent immunity, Pneumocystis pneumonia. Pneumocystis jirovecii infection was the first AIDS-defining illness and most closely tied with peripheral CD4+ T-cell counts. Due to successful control of HIV, the epidemiology of Pneumocystis infection in children is now primarily due to primary human immunodeficiencies and immunosuppressive therapies. To this end, we found that every human genetic immunodeficiency associated with Pneumocystis infection, recapitulated susceptibility in Pneumocystis infection in mice bearing similar mutations. Similar to human IL-21R deficiency, we found that IL-21R and CD4+ T-cell STAT3 signaling were required for both protective anti-fungal class-switched antibody responses and CD4+ effector T-cell mediated protection. Furthermore, we discerned that CD4+ T-cell intrinsic IL-21R/STAT3 signaling was required for inducing a Pneumocystis-specific IL-22 response, and that IL-22 inhibited trophozoite binding to alveolar epithelial cells. Moreover, recombinant IL-22 administration to Il21r−/− mice induced the expression of a fungicidal peptide, cathelicidin anti-microbial peptide which showed in vitro fungicidal activity. In conclusion, SPF laboratory mice faithfully replicate many aspects of human primary immunodeficiency and provide useful tools to understand the generation and nature of effector CD4+ T-cell immunity.

immunology